Activity To Improve Outcomes in Peripheral Arterial Disease
NCT ID: NCT02189018
Last Updated: 2023-07-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
208 participants
INTERVENTIONAL
2014-08-31
2023-07-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Multifactor Risk Reduction for Optimal Management of PAD
NCT00537225
Micro- and Macrovascular Adaptations in Patients With Peripheral Arterial Disease During Supervised Exercise Therapy
NCT00675402
Impact and Safety of Blood Flow Restriction in Patients With Peripheral Arterial Occlusive Disease
NCT07043114
Improving Walking in Peripheral Artery Disease
NCT05103280
Evaluation of FM220 in Patients With Peripheral Arterial Disease (PAD)
NCT00146666
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
We hypothesize that patients who undergo an exercise intervention will: A) show improved lower extremity perfusion and B) improve their functional ability, compared to a standard care control group over 6 months of follow-up. We further hypothesize that these improvements are mediated through angiogenesis and increased perfusion of the lower limb, as well as improvements in muscle strength, mass, and function.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
Ad lib activity at home
Ad lib activity at home
Ad lib activity at home
Active Exercise
Active exercise on treadmill
Active Exercise
Active exercise on a treadmill
Neuromuscular electrical stimulation
Neuromuscular electrical stimulation
Neuromuscular electrical stimulation
Neuromuscular electrical stimulation
Weight loss and active exercise
Weight loss plus active exercise on treadmill
Weight loss and active exercise
Weight loss and active exercise on a treadmill
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Active Exercise
Active exercise on a treadmill
Neuromuscular electrical stimulation
Neuromuscular electrical stimulation
Weight loss and active exercise
Weight loss and active exercise on a treadmill
Ad lib activity at home
Ad lib activity at home
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ankle brachial index \< 0.9
Exclusion Criteria
* Planned for open lower extremity bypass surgery
* Body mass index \>45
* Lower extremity gangrene
21 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Baltimore VA Medical Center
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Brajesh K Lal
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Brajesh K Lal, MD
Role: PRINCIPAL_INVESTIGATOR
Baltimore VAMC, University of Maryland School of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Baltimore VAMC
Baltimore, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HP-00059151
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.